We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Accelerating Cancer Immune Cell Therapies

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life. Cell therapies, including chimeric antigen receptor (CAR) T-cell therapy, are emerging as promising treatments, especially for hematological malignancies. However, many challenges remain in the development of this emerging class of therapeutics, from deepening responses in blood-based tumors to expanding efficacy in solid tumors.

Download this whitepaper to learn more about:

  • The mechanisms behind response
  • Resistance and toxicity to cell therapies
  • Identifying key biomarkers